Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth

Overview of attention for article published in Molecular Cancer, February 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 35 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Method for predicting responsiveness to cancer treatment using p300-inhibiting compound

Grant US-10768179-B2

United States of America

METHOD FOR PREDICTING RESPONSIVENESS TO CANCER TREATMENT USING p300-INHIBITING COMPOUND

Application EP-3121274-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.